Year archive

Aptose Biosciences Inc. — 2024 filings

All 49 regulatory filings released by Aptose Biosciences Inc. (APS) in 2024, sourced directly from the official regulator.

49 Filings

2024 Period

2024 filings (49)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2024-12-19	English
Other.pdf Proxy Solicitation & Information Statement	2024-12-17	English
News release - English.pdf Regulatory Filings	2024-12-12	English
News release - English.pdf Regulatory Filings	2024-12-09	English
Other.pdf Capital/Financing Update	2024-12-03	English
Other.pdf Report Publication Announcement	2024-12-03	English
Material document(s).pdf Capital/Financing Update	2024-12-03	English
Material change report - English.pdf Capital/Financing Update	2024-12-03	English
News release - English.pdf Regulatory Filings	2024-12-03	English
News release - English.pdf Capital/Financing Update	2024-11-22	English
News release - English.pdf Regulatory Filings	2024-11-20	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-11-09	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-11-09	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-11-09	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-11-09	English
News release - English.pdf Interim / Quarterly Report	2024-11-08	English
Other.pdf Delisting Announcement	2024-10-04	English
Material document(s).pdf Governance Information	2024-09-12	English
Material change report - English.pdf Regulatory Filings	2024-09-12	English
Material document(s).pdf Regulatory Filings	2024-09-12	English
Report of voting results.pdf Declaration of Voting Results & Voting Rights Announcements	2024-09-09	English
News release - English.pdf Capital/Financing Update	2024-09-05	English
News release - English.pdf Capital/Financing Update	2024-08-30	English
News release - English.pdf Regulatory Filings	2024-08-15	English
Other.pdf Investor Presentation	2024-07-26	English
Other.pdf Proxy Solicitation & Information Statement	2024-07-05	English
News release - English.pdf Investor Presentation	2024-06-14	English
News release - English.pdf Capital/Financing Update	2024-06-03	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2024-05-17	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2024-05-17	English
Other.pdf Regulatory Filings	2024-05-17	English
Notice of meeting - English.pdf AGM Information	2024-05-17	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-15	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-15	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-05-15	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-05-15	English
News release - English.pdf Interim / Quarterly Report	2024-05-14	English
News release - English.pdf Report Publication Announcement	2024-05-06	English
Notice of the meeting and record date (amended) - English.pdf Regulatory Filings	2024-04-17	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-03-26	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-03-26	English
Annual report on form 10-K - English.pdf Annual Report	2024-03-26	English
Annual MD&A - English.pdf Annual Report	2024-03-26	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-03-26	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-03-26	English
Audited annual financial statements – English.pdf Annual Report	2024-03-26	English
News release - English.pdf Annual Report	2024-03-26	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2024-03-19	English
News release - English.pdf Earnings Release	2024-03-18	English